Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ArmiCare is a premium topical antimicrobial and skin care product developed by Armis Biopharma, introduced in 2021. It is formulated as a hand sanitizer and wound care solution that leverages the company's proprietary Veriox technology platform, which is a peracid/hydrogen peroxide-based non-systemic antimicrobial system. The product contains 75% ethyl alcohol as its primary active ingredient, supplemented with hydrogen peroxide for enhanced disinfecting and sanitizing properties. To counteract the drying effects of alcohol, the formulation includes glycerin for its healing and moisturizing qualities and lavender to soothe the skin. ArmiCare is classified as a medical device and is intended to kill germs and bacteria while maintaining skin hydration and smoothness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ArmiCare.